Sidenius N - Search Results

1

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Andolfo A, et al. Among authors: sidenius n. Thromb Haemost. 2002 Aug;88(2):298-306. Thromb Haemost. 2002. PMID: 12195704

2

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Sidenius N, Andolfo A, Fesce R, Blasi F. Sidenius N, et al. J Biol Chem. 2002 Aug 2;277(31):27982-90. doi: 10.1074/jbc.M111736200. Epub 2002 May 28. J Biol Chem. 2002. PMID: 12034711 Free article.

3

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

4

The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.

Alfano M, Sidenius N, Blasi F, Poli G. Alfano M, et al. Among authors: sidenius n. J Leukoc Biol. 2003 Nov;74(5):750-6. doi: 10.1189/jlb.0403176. Epub 2003 Aug 21. J Leukoc Biol. 2003. PMID: 12960238 Review.

5

Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N. Cunningham O, et al. Among authors: sidenius n. EMBO J. 2003 Nov 17;22(22):5994-6003. doi: 10.1093/emboj/cdg588. EMBO J. 2003. PMID: 14609946 Free PMC article.

6

Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.

Sier CF, Nicoletti I, Santovito ML, Frandsen T, Aletti G, Ferrari A, Lissoni A, Giavazzi R, Blasi F, Sidenius N. Sier CF, et al. Among authors: sidenius n. Thromb Haemost. 2004 Feb;91(2):403-11. doi: 10.1160/TH03-06-0351. Thromb Haemost. 2004. PMID: 14961171

7

Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR).

Resnati M, Pallavicini I, Daverio R, Sidenius N, Bonini P, Blasi F. Resnati M, et al. Among authors: sidenius n. J Immunol Methods. 2006 Jan 20;308(1-2):192-202. doi: 10.1016/j.jim.2005.10.013. Epub 2005 Dec 19. J Immunol Methods. 2006. PMID: 16386755

8

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N. Blasi F, et al. Among authors: sidenius n. FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. FEBS Lett. 2010. PMID: 20036661 Free article. Review.

9

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. Fazioli F, et al. Among authors: sidenius n. EMBO J. 1997 Dec 15;16(24):7279-86. doi: 10.1093/emboj/16.24.7279. EMBO J. 1997. PMID: 9405357 Free PMC article.

10

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F. Sidenius N, et al. FEBS Lett. 2000 Mar 17;470(1):40-6. doi: 10.1016/s0014-5793(00)01282-5. FEBS Lett. 2000. PMID: 10722842 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters